How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

November 5, 2026

Early Release – Characteristics of and Clinical Criteria for Oropouche Virus Disease, United States, May 2024–January 2025 – Volume 32, Supplement—December 2026 – Emerging Infectious Diseases journal

Oropouche virus (OROV) is a biting midge–borne orthobunyavirus (Simbu serogroup) that was identified in Trinidad

November 5, 2026 No Comments

Early Release – Characteristics of and Clinical Criteria for Oropouche Virus Disease, United States, May 2024–January 2025 – Volume 32, Supplement—December 2026 – Emerging Infectious Diseases journal

Oropouche virus (OROV) is a biting midge–borne orthobunyavirus (Simbu serogroup) that was identified in Trinidad

November 5, 2026 No Comments

Early Release – Characteristics of and Clinical Criteria for Oropouche Virus Disease, United States, May 2024–January 2025 – Volume 32, Supplement—December 2026 – Emerging Infectious Diseases journal

New World Hantavirus Entry Mechanism Revealed

Democratic doctors win big in 2026 midterm elections

Quick takes: Salmonella tied to oysters, Bundibugyo vaccine funding, no mother-to-child HIV in Barbados

Early Release – Characteristics of and Clinical Criteria for Oropouche Virus Disease, United States, May 2024–January 2025 – Volume 32, Supplement—December 2026 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us